Stereotaxis, Inc. (STXS) Key Statistics & Financial Ratios

Stereotaxis, Inc. (STXS) — Price $1.32 HealthcareMedical - Instruments & Supplies — AMEX

Latest reported results:

Key statistics dashboard for Stereotaxis, Inc. (STXS). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

Stock Data

Price$1.32
Market Cap$129M
Enterprise Value$124.0M
Beta1.42
ExchangeAMEX
CountryUS

Valuation Multiples

P/E Ratio-5.34
Price / Book7.56
P/S4.30
EV/EBITDA-5.87
EV/Sales4.12
EV/FCF-8.00
P/FCF-8.34
Earnings Yield-16.91%
FCF Yield-11.99%
Dividend Yield0.00%

Profitability

Gross Margin55.57%
EBIT Margin-74.24%
EBITDA Margin-70.28%
Operating Margin-73.02%
Net Margin-74.24%
Return on Equity-132.62%
Return on Assets-40.16%
Return on Invested Capital-74.49%
Return on Capital Employed-76.27%

Financial Health

Current Ratio1.42
Quick Ratio0.95
Cash Ratio0.39
Debt / Equity0.30
Debt / Assets9.31%
Net Debt / EBITDA0.25
Interest Coverage0.00

Per-Share Data

Revenue per share0.30
Book Value per share0.17
Cash per share0.10
FCF per share-0.15
Tangible Book Value per share0.08
Dividend per share0.00

Related companies: ARCT · CVRX · HUMA · MDXH · NEO · OSUR · QTRX

Explore sector: Healthcare · Medical - Instruments & Supplies

More sections of STXS: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks